Pasteur Institute Develops Alzheimer Blood Test for Diabetics

Since 2023, research teams at the Pasteur Institute of Tunisia have been studying genetic factors that explain the decline in cognitive abilities among some diabetic patients, with the aim of early detection of their potential risk of developing Alzheimer's disease. Studies indicate that approximately 70% of individuals with diabetes are at risk of experiencing cognitive decline, which increases the likelihood of developing the disease. The researchers are currently analyzing 100 samples to identify scientific indicators that can help understand the relationship between diabetes and Alzheimer's, with plans to expand the study later. The goal of this research is to develop blood and genetic tests that can preemptively identify those most at risk, enabling early intervention, reducing symptom progression, and improving patient healthcare.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل